Antiretroviral drug levels and interactions affect lipid, lipoprotein and glucose metabolism in HIV-1 seronegative subjects: A pharmacokinetic-pharmacodynamic analysis

Por Rosenkranz, Susan L., Yarasheski, Kevin E., Para, Michael F., Reichman, Richard C., Morse, Gene D.
Publicado em 2007

The Design of Single-Arm Clinical Trials of Combination Antiretroviral Regimens for Treatment-Naive HIV-Infected Patients

Por Zheng, Lu, Rosenkranz, Susan L., Taiwo, Babafemi, Para, Michael F., Eron, Joseph J., Hughes, Michael D.
Publicado em 2013

The Pharmacokinetics and Pharmacogenomics of Efavirenz and Lopinavir/Ritonavir in HIV-Infected Persons Requiring Hemodialysis

Por Gupta, Samir K., Rosenkranz, Susan L., Cramer, Yoninah S., Koletar, Susan L., Szczech, Lynda A., Amorosa, Valerianna, Hall, Stephen D.
Publicado em 2008

Pharmacokinetic Interaction between Efavirenz and Dual Protease Inhibitors in Healthy Volunteers

Por Ma, Qing, Forrest, Alan, Rosenkranz, Susan L., Para, Michael F., Yarasheski, Kevin E., Reichman, Richard C., Morse, Gene D.
Publicado no Biopharm Drug Dispos (2008)

Early HIV RNA decay during raltegravir-containing regimens exhibits two distinct subphases (1a and 1b)

Por Andrade, Adriana, Guedj, Jeremie, Rosenkranz, Susan L., Lu, Darlene, Mellors, John, Kuritzkes, Daniel R., Perelson, Alan S., Ribeiro, Ruy M.
Publicado no AIDS (2015)

Pharmacokinetic interaction between nelfinavir and pravastatin in HIV-seronegative volunteers: ACTG Study A5108

Por Aberg, Judith A., Rosenkranz, Susan L., Fichtenbaum, Carl J., Alston, Beverly L., Brobst, Susan W., Segal, Yoninah, Gerber, John G.
Publicado em 2006

Clinical Pharmacology Quality Assurance (CPQA) Program: Models for Longitudinal Analysis of Antiretroviral (ARV) Proficiency Testing for International Laboratories

Por DiFrancesco, Robin, Rosenkranz, Susan L., Taylor, Charlene R., Pande, Poonam G., Siminski, Suzanne M., Jenny, Richard W., Morse, Gene D.
Publicado em 2013

Adding value to antiretroviral proficiency testing

Por DiFrancesco, Robin, Taylor, Charlene R., Rosenkranz, Susan L., Tooley, Kelly M., Pande, Poonam G., Siminski, Suzanne M., Jenny, Richard W., Morse, Gene D.
Publicado no Bioanalysis (2014)

Combined Effect of CYP2B6 and NAT2 Genotype on Plasma Efavirenz Exposure During Rifampin-based Antituberculosis Therapy in the STRIDE Study

Por Luetkemeyer, Anne F., Rosenkranz, Susan L., Lu, Darlene, Grinsztejn, Beatriz, Sanchez, Jorge, Ssemmanda, Michael, Sanne, Ian, McIlleron, Helen, Havlir, Diane V., Haas, David W.
Publicado no Clin Infect Dis (2015)

Relationship Between Weight, Efavirenz Exposure, and Virologic Suppression in HIV-Infected Patients on Rifampin-Based Tuberculosis Treatment in the AIDS Clinical Trials Group A5221...

Por Luetkemeyer, Anne F., Rosenkranz, Susan L., Lu, Darlene, Marzan, Florence, Ive, Prudence, Hogg, Evelyn, Swindells, Susan, Benson, Constance A., Grinsztejn, Beatriz, Sanne, Ian M., Havlir, Diane V., Aweeka, Francesca
Publicado em 2013

Phase I/II Trial of the Anti-HIV Activity of Mifepristone in HIV-Infected Subjects ACTG 5200

Por Para, Michael F., Schouten, Jeff, Rosenkranz, Susan L., Yu, Song, Weiner, David, Tebas, Pablo, White, C. Jo, Reeds, Dominic, Lertora, Juan, Patterson, Kristine B., Daar, Eric S., Cavert, Wintson, Brizz, Barbara
Publicado em 2010

COMPARISON OF ONCE-DAILY VERSUS TWICE-DAILY COMBINATION ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE PATIENTS: RESULTS OF AIDS CLINICAL TRIALS GROUP (ACTG) A5073, A 48-WEEK RANDOMIZED...

Por Flexner, Charles, Tierney, Camlin, Gross, Robert, Andrade, Adriana, Lalama, Christina, Eshleman, Susan H., Aberg, Judith, Sanne, Ian, Parsons, Teresa, Kashuba, Angela, Rosenkranz, Susan L., Kmack, Anne, Ferguson, Elaine, Dehlinger, Marjorie, Mildvan, Donna
Publicado em 2010

Three Distinct Phases of HIV-1 RNA Decay in Treatment-Naive Patients Receiving Raltegravir-Based Antiretroviral Therapy: ACTG A5248

Por Andrade, Adriana, Rosenkranz, Susan L., Cillo, Anthony R., Lu, Darlene, Daar, Eric S., Jacobson, Jeffrey M., Lederman, Michael, Acosta, Edward P., Campbell, Thomas, Feinberg, Judith, Flexner, Charles, Mellors, John W., Kuritzkes, Daniel R.
Publicado em 2013

Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Naïve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine

Por Funderburg, Nicholas T., Andrade, Adriana, Chan, Ellen S., Rosenkranz, Susan L., Lu, Darlene, Clagett, Brian, Pilch-Cooper, Heather A., Rodriguez, Benigno, Feinberg, Judith, Daar, Eric, Mellors, John, Kuritzkes, Daniel, Jacobson, Jeffrey M., Lederman, Michael M.
Publicado em 2013

Binge Drinking is Associated with Differences in Weekday and Weekend Adherence in HIV-Infected Individuals

Por De Boni, Raquel B., Zheng, Lu, Rosenkranz, Susan L., Sun, Xin, Lavenberg, Jeffrey, Cardoso, Sandra W., Grinsztejn, Beatriz, La Rosa, Alberto, Pierre, Samuel, Severe, Patrice, Cohn, Susan E., Collier, Ann C., Gross, Robert
Publicado no Drug Alcohol Depend (2015)

Safety, Tolerability and Mechanisms of Antiretroviral Activity of Peginterferon alfa-2a in HIV-1-Mono-infected Subjects: A Phase II Clinical Trial

Por Asmuth, David M, Murphy, Robert L, Rosenkranz, Susan L, Lertora, Juan J L, Kottilil, Shyam, Cramer, Yoninah, Chan, Ellen S, Schooley, Robert T, Rinaldo, Charles R, Thielman, Nathan, Li, Xiao-Dong, Wahl, Sharon M, Shore, Jessica, Janik, Jennifer, Lempicki, Richard A, Simpson, Yaa, Pollard, Richard B
Publicado em 2010

Partner-Focused Adherence Intervention for Second-line Antiretroviral Therapy: A Multinational Randomized Trial (ACTG A5234)

Por Gross, Robert, Zheng, Lu, La Rosa, Alberto, Sun, Xin, Rosenkranz, Susan L., Cardoso, Sandra Wagner, Ssali, Francis, Camp, Rob, Godfrey, Catherine, Cohn, Susan E., Robbins, Gregory K., Chisada, Anthony, Wallis, Carole L., Reynolds, Nancy R., Lu, Darlene, Safren, Steven A., Hosey, Lara, Severe, Patrice, Collier, Ann C.
Publicado no Lancet HIV (2015)